P3 Health Partners [PIII] vs Pacs [PACS] Detailed Stock Comparison

P3 Health Partners
NASDAQ
Loading...

Pacs
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: P3 Health Partners wins in 8 metrics, Pacs wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | P3 Health Partners | Pacs | Better |
---|---|---|---|
P/E Ratio (TTM) | -0.15 | 19.41 | P3 Health Partners |
Price-to-Book Ratio | 0.53 | 3.15 | P3 Health Partners |
Debt-to-Equity Ratio | 221.06 | 469.36 | P3 Health Partners |
PEG Ratio | 0.00 | 6.61 | P3 Health Partners |
EV/EBITDA | -0.95 | 17.61 | P3 Health Partners |
Profit Margin (TTM) | -9.99% | 2.59% | Pacs |
Operating Margin (TTM) | -9.59% | 0.07% | Pacs |
EBITDA Margin (TTM) | N/A | 0.07% | N/A |
Return on Equity | -141.55% | 110.96% | Pacs |
Return on Assets (TTM) | -24.31% | 3.21% | Pacs |
Free Cash Flow (TTM) | $-110.13M | $-109.11M | Pacs |
1-Year Return | -70.58% | -71.61% | P3 Health Partners |
Price-to-Sales Ratio (TTM) | 1.00 | 0.52 | Pacs |
Enterprise Value | $219.57M | $4.39B | Pacs |
EV/Revenue Ratio | 0.15 | 1.23 | P3 Health Partners |
Gross Profit Margin (TTM) | N/A | 15.67% | N/A |
Revenue per Share (TTM) | $449 | $27 | P3 Health Partners |
Earnings per Share (Diluted) | $-51.33 | $0.61 | Pacs |
Beta (Stock Volatility) | 0.80 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
P3 Health Partners vs Pacs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
P3 Health Partners | -0.07% | 5.33% | 9.92% | -6.40% | -29.71% | -41.52% |
Pacs | -1.59% | 1.73% | 0.95% | 18.72% | -8.29% | -9.28% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
P3 Health Partners | -70.58% | -96.88% | -98.50% | -98.50% | -98.50% | -98.50% |
Pacs | -71.61% | -51.13% | -51.13% | -51.13% | -51.13% | -51.13% |
Performance & Financial Health Analysis: P3 Health Partners vs Pacs
Metric | PIII | PACS |
---|---|---|
Market Information | ||
Market Cap | $1.46B | $1.84B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 4,156 | 403,171 |
90 Day Avg. Volume | 9,609 | 479,024 |
Last Close | $7.31 | $11.73 |
52 Week Range | $5.80 - $29.20 | $8.28 - $43.92 |
% from 52W High | -74.97% | -73.29% |
All-Time High | $16.73 (Dec 06, 2021) | $43.92 (Oct 28, 2024) |
% from All-Time High | -56.31% | -73.29% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.06% | 0.29% |
Quarterly Earnings Growth | -0.06% | N/A |
Financial Health | ||
Profit Margin (TTM) | -0.10% | 0.03% |
Operating Margin (TTM) | -0.10% | 0.00% |
Return on Equity (TTM) | -1.42% | 1.11% |
Debt to Equity (MRQ) | 221.06 | 469.36 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $13.60 | $3.75 |
Cash per Share (MRQ) | $11.81 | $0.48 |
Operating Cash Flow (TTM) | $-129,955,000 | $99.09M |
Levered Free Cash Flow (TTM) | $-1,812,750 | $1.62B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: P3 Health Partners vs Pacs
Metric | PIII | PACS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -0.15 | 19.41 |
Forward P/E | -34.14 | 6.61 |
PEG Ratio | 0.00 | 6.61 |
Price to Sales (TTM) | 1.00 | 0.52 |
Price to Book (MRQ) | 0.53 | 3.15 |
Market Capitalization | ||
Market Capitalization | $1.46B | $1.84B |
Enterprise Value | $219.57M | $4.39B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.15 | 1.23 |
Enterprise to EBITDA | -0.95 | 17.61 |
Risk & Other Metrics | ||
Beta | 0.80 | N/A |
Book Value per Share (MRQ) | $13.60 | $3.75 |
Financial Statements Comparison: P3 Health Partners vs Pacs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PIII | PACS |
---|---|---|
Revenue/Sales | $373.23M | $981.85M |
Cost of Goods Sold | N/A | $827.98M |
Gross Profit | N/A | $153.87M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-38.09M | $710,000 |
EBITDA | $-16.72M | $5.58M |
Pre-Tax Income | $-43.17M | $-12.38M |
Income Tax | $1.07M | $-1.47M |
Net Income (Profit) | $-44.25M | $-10.91M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PIII | PACS |
---|---|---|
Cash & Equivalents | $40.08M | $73.37M |
Total Current Assets | $191.44M | $800.65M |
Total Current Liabilities | $507.03M | $468.10M |
Long-Term Debt | $117.10M | $2.54B |
Total Shareholders Equity | $121.08M | $578.23M |
Retained Earnings | $-523.67M | $100.50M |
Property, Plant & Equipment | $1.08M | $2.15B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PIII | PACS |
---|---|---|
Operating Cash Flow | $-43.46M | $-33.46M |
Capital Expenditures | N/A | $-111.48M |
Free Cash Flow | $-33.47M | $-76.67M |
Debt Repayment | $-341,000 | $-465.05M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | PIII | PACS |
---|---|---|
Shares Short | 35,245 | 2.47M |
Short Ratio | 3.21 | 4.79 |
Short % of Float | 0.10% | N/A |
Average Daily Volume (10 Day) | 4,156 | 403,171 |
Average Daily Volume (90 Day) | 9,609 | 479,024 |
Shares Outstanding | 3.26M | 147.77M |
Float Shares | 1.23M | 43.04M |
% Held by Insiders | 0.62% | 0.72% |
% Held by Institutions | 0.11% | 0.29% |
Dividend Analysis & Yield Comparison: P3 Health Partners vs Pacs
Metric | PIII | PACS |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |